Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.
By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.
You're browsing as a guest. Some features like watchlists and alerts require a free account.

Waters Corporation
| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/21 | WAT | 8-K | Waters Corporation Announces Key Executive Changes | — | — | — |
| 08/04 | WAT | 8-K | Waters Corporation Reports Strong Q2 2026 Results and Raises Full-Year Guidance | — | — | — |
| 05/22 | WAT | 8-K | Waters Corporation Re-elects Board Members and Approves Key Proposals at Annual Meeting | — | — | — |
| 05/05 | WAT | 8-K | Waters Corporation Reports Strong Q1 2026 Results and Raises Full-Year Guidance | — | — | — |
| 03/23 | WAT | 8-K | Waters Corporation Subsidiary Completes $3.5 Billion Senior Notes Offering | — | — | — |
| 03/16 | WAT | 8-K | Waters Corporation Completes Acquisition of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions Business | — | — | — |
| 02/09 | WAT | 8-K | Waters Corporation Completes Spin-off and Combination with BD’s Biosciences and Diagnostic Solutions Businesses | — | — | — |
| 02/09 | WAT | 8-K | Waters Corporation Reports Strong 2025 Financial Results and Provides 2026 Outlook | — | — | — |
| 01/27 | WAT | 8-K | Waters Shareholders Approve Share Issuance for BD Biosciences Combination | — | — | — |
| 01/16 | WAT | 8-K | Waters Corporation Announces Spin-Off of Biosciences and Diagnostic Solutions Business | — | — | — |
| 01/12 | WAT | 8-K | Waters Corporation Presents Financial Outlook and Proposed Transaction at J.P. Morgan Healthcare Conference | — | — | — |
| 11/04/25 | WAT | 8-K | Waters Corporation Announces Third Quarter 2025 Financial Results and Raises Guidance | — | — | — |
| 08/04/25 | WAT | 8-K | Waters Corporation Reports Second Quarter 2025 Financial Results | — | — | — |
| 07/14/25 | WAT | 8-K | Waters Corporation Announces Proposed Transaction with BD's Biosciences and Diagnostics Solutions | — | — | — |
| 07/14/25 | WAT | 8-K | Waters Corporation Announces Reverse Morris Trust Transaction with Becton, Dickinson and Company | — | — | — |
| 05/29/25 | WAT | 8-K | Waters Corporation Amends Credit Agreement | — | — | — |
| 05/23/25 | WAT | 8-K | Waters Corporation Announces Election Results and Approvals from Annual Stockholder Meeting | — | — | — |
| 05/06/25 | WAT | 8-K | Waters Corporation Reports Strong First Quarter 2025 Financial Results | — | — | — |
| 02/12/25 | WAT | 8-K | Waters Corporation Reports Strong 2024 Financial Results and Provides 2025 Guidance | — | — | — |
| 01/13/25 | WAT | 8-K | Waters Corporation to Present at J.P. Morgan Healthcare Conference | — | — | — |
| 11/01/24 | WAT | 8-K | Waters Corporation Reports Strong Q3 2024 Results and Raises Guidance | — | — | — |
| 11/01/24 | WAT | 8-K | Waters Corporation Appoints Heather Knight to Board and Committee | — | — | — |
Waters Corporation (WAT): 22 8-K filings summarized, the most recent on Aug 21, 2026.
On August 17, 2026, Waters Corporation announced the resignation of Robert L. Carpio III from his position as Senior Vice President, Waters Analytical Sciences Division, effective August 20, 2026. Tina Wu, currently Senior Vice President, Waters Materials Sciences Division and President, China, will assume the role of…
Waters Corporation Announces Key Executive ChangesWaters Corporation announced its financial results for the second quarter of 2026, reporting total revenue of $1.645 billion, which surpassed the high end of the guidance range. Organic revenue grew 7% as reported and 9% in constant currency, driven by broad-based outperformance across both organic revenue and the…
Waters Corporation Reports Strong Q2 2026 Results and Raises Full-Year GuidanceAt the annual meeting of stockholders held on May 21, 2026, Waters Corporation re-elected all nominated directors to its Board, ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved a non-binding advisory resolution on executive compensation. The…
Waters Corporation Re-elects Board Members and Approves Key Proposals at Annual MeetingWaters Corporation announced its first quarter 2026 financial results, reporting total revenue of $1.267 billion, which exceeded the high end of the guidance range by $56 million. Organic revenue grew 13% as reported and 11% in constant currency, driven by strong performance in the Analytical Sciences Division. The…
Waters Corporation Reports Strong Q1 2026 Results and Raises Full-Year GuidanceOn March 23, 2026, Augusta SpinCo Corporation, a subsidiary of Waters Corporation, completed the public offering of $3.5 billion aggregate principal amount of senior notes due between 2027 and 2036. The notes were issued under an Indenture and are guaranteed by Waters Corporation and certain subsidiaries. The proceeds…
Waters Corporation Subsidiary Completes $3.5 Billion Senior Notes Offering